Mark Wilks Selected Research

Mark Wilks Research Topics

4	Infections 01/2022 - 02/2015
2	Peritonitis 01/2021 - 01/2006
2	Neoplasms (Cancer) 11/2017 - 07/2012
2	Chronic Obstructive Pulmonary Disease (COPD) 02/2015 - 08/2004
2	Aspergillosis 07/2012 - 09/2006
1	Necrotizing Enterocolitis 06/2017
1	Dysbiosis 06/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2015
1	Mycoses (Diseases, Fungus) 07/2012
1	Rupture 03/2010
1	Ventilator-Associated Pneumonia 07/2006
1	Emphysema 08/2004
1	Bronchiectasis 08/2004
1	Bacterial Vaginosis 02/2004

3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2006
2	Oxygen (Dioxygen)IBA 11/2017 - 08/2004
1	SolutionsIBA 01/2021
1	25-hydroxyvitamin DIBA 02/2015
1	Cholecalciferol (Vitamin D3)FDA Link 02/2015
1	Vitamin D FDA LinkGeneric 02/2015
1	Sodium Glutamate (Accent)IBA 07/2012
1	A-Form DNA (A-DNA)IBA 03/2010
1	Fungal DNAIBA 09/2006
1	Colistin (Coly-Mycin)FDA Link 07/2006
1	Bacterial DNAIBA 01/2006
1	Interleukin-8 (Interleukin 8)IBA 08/2004
1	CytokinesIBA 08/2004
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2004

2	Peritoneal Dialysis 01/2021 - 01/2006
1	Antibiotic Prophylaxis 01/2022
1	Artificial Respiration (Mechanical Ventilation) 07/2006
1	Therapeutics 01/2006